FEATURED ARTICLE

 

Ortho Clinical Diagnostics and Sphingotec Announce Strategic Agreement Regarding Novel Biomarker for Decreasing Re-hospitalizations in Heart Failure

PR Newswire  2017-12-07 13:30:00

RARITAN, N.J. and HENNIGSDORF, Germany, Dec. 7, 2017 /PRNewswire/ -- Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, and sphingotec GmbH today announced a long-term, global strategic agreement regarding the endothelial function marker, biologically active...

Full Story »

Comments

No Comments
Your name: *
Email:
Comment: *
 
Share
submit to reddit
Save On Airport Parking